by Sam Eskandari | Feb 4, 2019 | News
VANCOUVER, British Columbia, Feb. 04, 2019 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces that it is proceeding with a consolidation of its issued and outstanding common shares at a ratio of one (1)...
by Sam Eskandari | Jan 15, 2019 | News
January 15, 2019, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered into a Memorandum of Understanding (“MOU”) with Santa Marta Gold Holdings Ltd. (“Santa Marta”)...
by Sam Eskandari | Dec 21, 2018 | News
December 21, 2018, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that the Company has entered into a share exchange agreement with three separate individuals for the issuance of...
by Sam Eskandari | Dec 20, 2018 | News
December 20, 2018, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce the appointment of Blair Lowther as the Corporate Secretary of the Company. Blair is a corporate lawyer with many...
by Sam Eskandari | Nov 20, 2018 | News
November 20, 2018, Vancouver, BC – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce the appointment of Blair Lowther and Nick Standish as Directors of the Company. Lui Franciosi commented: “We are very...
